You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 2, 2024

ACARBOSE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


DrugPatentWatch® Litigation and Generic Entry Outlook for Acarbose

A generic version of ACARBOSE was approved as acarbose by HIKMA on May 7th, 2008.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for ACARBOSE?
  • What are the global sales for ACARBOSE?
  • What is Average Wholesale Price for ACARBOSE?
Summary for ACARBOSE
Drug patent expirations by year for ACARBOSE
Drug Prices for ACARBOSE

See drug prices for ACARBOSE

Recent Clinical Trials for ACARBOSE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Empros Pharma ABPhase 1
CTC Clinical Trial Consultants ABPhase 1
University Teaching Hospital, Lusaka, ZambiaPhase 3

See all ACARBOSE clinical trials

Pharmacology for ACARBOSE
Medical Subject Heading (MeSH) Categories for ACARBOSE
Paragraph IV (Patent) Challenges for ACARBOSE
Tradename Dosage Ingredient Strength NDA ANDAs Submitted Submissiondate
PRECOSE Tablets acarbose 25 mg, 50 mg and 100 mg 020482 1 2005-03-22

US Patents and Regulatory Information for ACARBOSE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Avet Lifesciences ACARBOSE acarbose TABLET;ORAL 202271-001 Feb 7, 2012 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Strides Pharma ACARBOSE acarbose TABLET;ORAL 090912-003 Jul 27, 2011 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Watson Labs ACARBOSE acarbose TABLET;ORAL 077532-003 May 7, 2008 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Hangzhou Zhongmei ACARBOSE acarbose TABLET;ORAL 213821-001 Aug 18, 2020 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Dash Pharms ACARBOSE acarbose TABLET;ORAL 091053-001 Jan 6, 2011 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.